LAVA Therapeutics N.V. announced Ed Smith, chief financial officer has resigned to pursue other interests, effective as of May 17, 2022. He may serve in a consulting capacity to support the Company's transition. The Company has commenced a search for Mr. Smith's permanent replacement.